OPUGOTAMIG OLATANSINE
UNII 8R9DRT37YD

Substance Identification & Data

This profile provides standardized clinical and technical data for Opugotamig Olatansine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8R9DRT37YD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2779564-40-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8R9DRT37YD
CAS Registry Number
2779564-40-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
OPUGOTAMIG OLATANSINE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C191851
National Cancer Institute reference terminology for clinical and research data.
INN ID
12957
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Opugotamig Olatansine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OPUGOTAMIG OLATANSINE

Common Names & Synonyms

IMMUNOGLOBULIN, ANTI-(HUMAN FOLATE RECEPTOR .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL FR1-57 SINGLE-CHAIN FV FRAGMENT VL-(GGGGS)4-VH)FUSION PROTEIN WITH PEPTIDE LINKER (GS) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (4-SERINE,151-TRYPTOPHAN,DE-232-LYSINE) (HUMAN .GAMMA.1-CHAIN C REGION C-TERMINAL FRAGMENT), (259->227'),(262->230')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 ANTI-(HUMAN FOLATE RECEPTOR .ALPHA.) (367-SERINE,369-ALANINE,408-VALINE,DE-448-LYSINE) (HUMAN-MUS MUSCULUS MONOCLONAL MOV-19 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MOV-19 .KAPPA.-CHAIN, N6-AMIDE WITH N2'-(6-((((N-(4-((1-(3-CARBOXYPROPYL)-2,5-DIOXO-3-PYRROLIDINYL)THIO)-1-OXOBUTYL)-L-ALANYL-D-ALANYL-L-ALANYL)AMINO)METHYL)THIO)-1-OXOHEXYL)-N2'-DEACETYLMAYTANSINE
OPUGOTAMIG OLATANSINE [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus